News for 4Sc AG (VSC.BE)

Long history of success in fighting infectious diseases - ready for future growthAiCuris has been focusing on the identification and development of novel treatments to fight infectious diseases with high medical needs driven by understanding the indication and selecting the appropriate approach, since the Company was spun-out from Bayer's anti-infective unit in 2006. The Company's first product, Prevymis(R) (letermovir), a novel therapy for human cytomegalovirus (HCMV) infections is revolutionizing transplant medicine.